These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 29936749)

  • 1. [Effect of influenza and 23-valent pneumococcal polysaccharide vaccinations on elderly with chronic obstructive pulmonary diseases: a community-based intervention study].
    Wen Y; He L; Zhai Y; Wu J; Chen YY; Wang H; Zong QQ; Liang XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):792-798. PubMed ID: 29936749
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study.
    Kondo K; Suzuki K; Washio M; Ohfuji S; Fukushima W; Maeda A; Hirota Y;
    Vaccine; 2017 Aug; 35(36):4806-4810. PubMed ID: 28818473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program.
    Tsai YH; Hsieh MJ; Chang CJ; Wen YW; Hu HC; Chao YN; Huang YC; Yang CT; Huang CC
    Vaccine; 2015 Jun; 33(25):2897-902. PubMed ID: 25936662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of influenza and pneumococcal vaccines on chronic obstructive pulmonary disease exacerbations.
    Li Y; Zhang P; An Z; Yue C; Wang Y; Liu Y; Yuan X; Ma Y; Li K; Yin Z; Wang L; Wang H
    Respirology; 2022 Oct; 27(10):844-853. PubMed ID: 35705329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive preventive effect of influenza and pneumococcal vaccines in the elderly: results of a large cohort study.
    Mahamat A; Daurès JP; de Wzieres B
    Hum Vaccin Immunother; 2013 Jan; 9(1):128-35. PubMed ID: 23442587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with influenza and pneumococcal vaccination among patients with chronic obstructive pulmonary disease consulting their medical practitioners in Catalonia, Spain.
    Jiménez-García R; Ariñez-Fernandez MC; Hernández-Barrera V; Garcia-Carballo MM; de Miguel AG; Carrasco-Garrido P
    J Infect; 2007 Jan; 54(1):65-74. PubMed ID: 17049991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A formative research-guided educational intervention to improve the knowledge and attitudes of seniors towards influenza and pneumococcal vaccinations.
    Ho HJ; Chan YY; Ibrahim MAB; Wagle AA; Wong CM; Chow A
    Vaccine; 2017 Nov; 35(47):6367-6374. PubMed ID: 29031694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.
    Domínguez A; Castilla J; Godoy P; Delgado-Rodríguez M; Saez M; Soldevila N; Astray J; Mayoral JM; Martín V; Quintana JM; González-Candelas F; Galán JC; Tamames S; Castro A; Baricot M; Garín O; Pumarola T;
    Hum Vaccin Immunother; 2013 Apr; 9(4):865-73. PubMed ID: 23563516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with pneumococcal vaccination among an urban elderly population in China.
    Liu S; Xu E; Liu Y; Xu Y; Wang J; Du J; Zhang X; Che X; Gu W
    Hum Vaccin Immunother; 2014; 10(10):2994-9. PubMed ID: 25483646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysis.
    Zhang YY; Tang XF; Du CH; Wang BB; Bi ZW; Dong BR
    Hum Vaccin Immunother; 2016 Dec; 12(12):3056-3064. PubMed ID: 27629584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Health economic evaluation of a 23 value pneumococcal polysaccharide vaccination pilot programme among elderly chronic obstructive pulmonary disease patients in China].
    Qiu YP; Zhao K; Li X; Shi LW; Guo WD; Qi XR; Sui BY; Zhou RM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1074-1078. PubMed ID: 28057111
    [No Abstract]   [Full Text] [Related]  

  • 12. Should Patients With COPD Be Vaccinated?
    Cimen P; Unlu M; Kirakli C; Katgi N; Ucsular FD; Ayranci A; Guclu SZ
    Respir Care; 2015 Feb; 60(2):239-43. PubMed ID: 25316894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the costs of a 13-valent pneumococcal conjugate vaccination program for home care patients.
    Linna M; Laine J; Timonen L; Åhman H; Tin Tin Htar M
    Curr Med Res Opin; 2018 Dec; 34(12):2089-2094. PubMed ID: 30114939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Pharmacist-Initiated Interventions on Vaccination Rates in Patients with Asthma or COPD.
    Klassing HM; Ruisinger JF; Prohaska ES; Melton BL
    J Community Health; 2018 Apr; 43(2):297-303. PubMed ID: 28852915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New ideas on the therapeutic effect of a combination of vaccines against pneumococcal, Haemophilus influenzae type b infection, and influenza in patients with chronic obstructive pulmonary disease].
    Kostinov MP; Zhestkov AV; Protasov AD; Magarshak OO; Kostinova TA
    Ter Arkh; 2015; 87(3):17-22. PubMed ID: 26027235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pneumococcal vaccine and influenza vaccine for prevention of exacerbation in patients with COPD].
    Matsuse H
    Nihon Rinsho; 2016 May; 74(5):839-42. PubMed ID: 27254956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older.
    Honkanen PO; Keistinen T; Miettinen L; Herva E; Sankilampi U; Läärä E; Leinonen M; Kivelä SL; Mäkelä PH
    Vaccine; 1999 Jun; 17(20-21):2493-500. PubMed ID: 10418894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of Streptococcus pneumoniae (pneumococcal) infections in adults].
    Ludwig E; Mészner Z;
    Orv Hetil; 2014 Dec; 155(50):1996-2004. PubMed ID: 25481502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab.
    Berglund A; Willén L; Grödeberg L; Skattum L; Hagberg H; Pauksens K
    Acta Oncol; 2014 Sep; 53(9):1212-20. PubMed ID: 24865118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of the 13-valent Pneumococcal Conjugate vaccine in 23-valent pneumococcal polysaccharide vaccine-naive and pre-immunized patients under treatment with chronic haemodialysis: a longitudinal quasi-experimental phase IV study.
    Vandecasteele SJ; De Bacquer D; Caluwe R; Ombelet S; Van Vlem B
    Clin Microbiol Infect; 2018 Jan; 24(1):65-71. PubMed ID: 28559003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.